The gut microbiome is linked to inflammatory bowel disease (IBD) severity and altered in late stage 16 disease. However, it is unclear how gut microbial communities change over the course of IBD 17 development, especially in regards to function. To investigate microbiome mediated disease 18 mechanisms and discover early biomarkers of IBD, we conducted a longitudinal metagenomic 19 investigation in an established mouse model of IBD, where dampened TGF-β signaling in T cells leads 20 to peripheral immune activation, weight loss, and severe colitis. IBD development is associated with 21 abnormal gut microbiome temporal dynamics, including dampened acquisition of functional diversity 22 and significant differences in abundance trajectories for KEGG modules such as glycosaminoglycan 23 degradation, cellular chemotaxis, and type III and IV secretion systems. Most differences between sick 24 and control mice emerge when mice begin to lose weight and heightened T cell activation is detected in 25 peripheral blood. However, lipooligosaccharide transporter abundance diverges prior to immune 26 activation, indicating that it could be a pre-disease indicator or microbiome-mediated disease 27 mechanism. Taxonomic structure of the gut microbiome also significantly changes in association with 28 IBD development, and the abundance of particular taxa, including several species of Bacteroides, 29 correlate with immune activation. These discoveries were enabled by our use of generalized linear 30 mixed effects models to test for differences in longitudinal profiles between healthy and diseased mice 31 while accounting for the distributions of taxon and gene counts in metagenomic data. These findings 32 demonstrate that longitudinal metagenomics is useful for discovering potential mechanisms through 33 which the gut microbiome becomes altered in IBD.
presence of certain inflammatory cytokines can instead divert differentiation of Tregs into pathogenic measured the longitudinal change in the CD44 hi activated fraction, which includes both effector and 135 memory T cells (Additional File 1: Figure S1 ). We also measured the weight of the animals over time 136 ( Fig. 1A ). As expected, WT mice gained weight and maintained a constant fraction of activated T cells.
137
DNR mice, conversely, stopped gaining weight and experienced a sharp increase in CD4 T cell 138 activation followed by gradual increase in CD8 T cell activation starting at 7 weeks of age ( Fig. 1 ).
139
These results indicate that in our facility, the DNR mice develop signs of IBD starting around week 7 140 and full disease by week 9. DNR mice had to be euthanized by week 15, as they had lost more than 141 15% of their maximum body weight. Similar to the T cell activation phenotype observed in the blood 142 after week 7 ( Fig. 1B-C) , the DNR animals had a larger fraction of activated T cells in the spleen and 143 the gut-draining mesenteric lymph node (MLN) at week 15 (Additional File 2: Figure S2 ).
145
We used shotgun metagenomics to assess how the functional potential of the gut microbiome 146 diversifies over the course of disease progression. Specifically, we collected stool samples from parallel 147 cohorts of DNR and WT mice weekly and performed shotgun metagenomic sequencing from samples 148 obtained at 4, 5, 6, 8, 10, 12, and 13 weeks of age (Additional File 3: Table S1 ). We then quantified the the overdispersion that is frequently present in environmental DNA sequence data, and its point mass 195 at zero allows for one-step fitting of zero-inflated data (versus fitting a model to determine feature 196 presence/absence before modeling non-zero components, as in hurdle models). Additionally, the 197 Tweedie compound Poisson is a continuous distribution, allowing us to use a normalized abundance 198 measure as the dependent variable, instead of raw counts. We provide a more detailed description of 199 the models used in our analysis in Additional Data File 5: Text S1.
201
We first looked at overall trends of abundance trajectories for DNR versus WT mice as quantified by the 202 interaction between genotype and time in the GLMM. These analyses revealed 29 KEGG modules with 203 significant differences in abundance trends between DNR and WT mice (FDR<0.05). The interaction 204 coefficient was positive for 26 of the significant modules (Additional File 6: Table S2 ), which indicates 205 that these modules became increasingly abundant in DNR versus WT mice over time. This set includes 206 modules associated with uridine monophosphate biosynthesis (M00051), keratin sulfate degradation 207 (M00079), and the type III secretion system (M00332). The three modules with negative interaction 208 coefficients, indicating decreasing abundance in DNR versus WT mice over time ( Fig. 3) , are lysine 209 biosynthesis (M00031), lipooligosaccharide transport (M00252), and melatonin biosynthesis (M00037).
211
To obtain improved temporal resolution regarding the divergence of module abundance in DNR mice,
212
we extended our GLMMs to include a "hinge" at week 7, which is when immune activation initiates in abundance between DNR and WT mice either between weeks 4 and 7 or between weeks 7 and 13. later weeks (Fig. 4 ). The discovery of stable, rather than decreasing, abundance of K03225 as an early 242 indicator of IBD in DNR mice is intriguing because Type III secretion systems are used by pathogens to 243 invade the gut community and alter the gut environment (68, 69).
245
We next examined baseline differences in module abundance between DNR and WT mice at weaning.
246
Early differences could result from genotype-specific selection of the gut microbiome or cage effects.
247
Our models revealed 17 modules with significantly different intercepts (q<0.05), which indicates 248 differences in abundance between the two lines at week 4 (Additional File 9: Table S4 ). Eight of these 249 modules, including several methanogenesis associated pathways, had positive intercept coefficients, 250 meaning that they were more abundant in DNR compared to WT mice at week 4. Lipopolysaccharide 251 biosynthesis and eight other modules showed the opposite effect and were higher in WT mice at 252 weaning. This early-life variation in the microbiome supports hypotheses that pre-adolescent 253 development of the microbiome can affect health state later in life. However, these temporal 254 relationships are complex: later changes in abundance, as captured by the time by cohort interaction, 255 could reverse the pattern seen at weaning.
257
To explore temporal dynamics of specific gut taxa, we applied the same GLMM analysis to species 258 abundances. This analysis yielded no significant results at FDR < 0.05, likely due to not having the 259 advantage of grouping components across a higher order variable. While species could be grouped into correlate with immune profiles and/or disease progression. Most of these discoveries would have been By using shotgun metagenomics, we were able to investigate both taxonomic and functional 296 characteristics of the IBD microbiome. Both types of data consistently showed differences between 297 DNR and WT mice. For example, beta-diversity analyses revealed increasing divergence of both 298 taxonomic and functional profiles between DNR and WT microbiomes over the last four weeks of the 299 study. In addition, the individual taxa and modules with genotype-specific trajectories predominantly 
313
Despite finding relatively few species that distinguish DNR mice, we can gain insight into the disease 314 process from what is known about how these taxa interact with the host. It is striking that four of the 315 seven species that change in abundance as IBD develops belong to the genus Bacteroides, three of 316 which are more abundant in DNR mice. Several studies have implicated Bacteroides in intestinal 317 inflammation. For example, a subset of B. fragilis strains carry a proinflammatory metalloprotease toxin 318 that has been identified in 19.3% of patients with active IBD (73), and the inoculation of animals with 319 such strains is associated with severe colitis (10, 74). Subsequent research showed that multiple 320 commensal species of Bacteroides could be incorporated into the gut microbiomes of IBD-susceptible that Bacteroides contribute to IBD, we observe a modest increase (q=0.1898) in the hemophore/metalloprotease transport system module (M00328) in DNR mice as disease progresses.
324
These and other mechanistic hypotheses must be tested, because the species of Bacteroides we 325 identified are diverse and species within the same genus can exhibit discordant patterns of interaction 326 with host physiology (76).
328
Cross-sectional and mechanistic investigations of IBD support our finding that disease development is 
366
Our identification of pathways that change in association with IBD development generates many novel 367 hypotheses about the mechanisms through which gut microbes contribute or respond to disease 368 development. Future studies can explicitly test these hypotheses to discern the cause and effect 369 relationship between the gut microbiome and inflammatory bowel disease. Several KEGG modules with 370 different abundance dynamics in DNR versus WT mice appear to be associated with the microbiome's 371 acclimation to the disease environment. For example, we observe increases in two-component systems 372 (M00511, M00482) that may contribute to a cell's ability to manage the elevated oxidative stress that 373 exists during active IBD (96). We also observe increases in pathways associated with cellular 374 chemotaxis (M00515, M00507). This result is consistent with observations of increased cell motility (22). This result also aligns with prior work that implicated toll-like receptor recognition of flagellar translocating across the gut epithelium, activate a chronic systemic inflammation that increases 404 cardiovascular disease risk. It is thus tempting to speculate that, based on our observations in these 405 mouse models of disease, IBD and perhaps HIV-associated changes in microbial metabolism of choline 406 contribute to or at least indicate this increased risk of cardiovascular disease.
408
Another intriguing hypothesis emerges from our observation that heme transport genes are elevated in 409 DNR mice as IBD develops. Bacteria use this module to scavenge iron from the environment. Iron is a 410 crucial component for many cellular processes, but gut microbes seldom have access to free iron and 411 instead sequester it from host sources, such as heme (106, 107). Heme concentrations may be 412 increased in IBD, as a common feature of the disease is intestinal bleeding (108). Hence, we 413 hypothesize that gut microbes that can take advantage of this heme may flourish in DNR mice. It is 414 intriguing to further speculate that microbial sequestration of heme contributes to IBD (e.g., through 415 signaling to the immune system) or to iron deficiency in IBD patients (109).
417
One surprising discovery was an increase in pathways associated with the production of benzoate 418 (M00538) in DNR mice. Benzoate is a carboxylic acid produced by microbial degradation of dietary 419 aromatic compounds and is a precursor of hippurate biosynthesis in mammals (110). Prior work 420 suggested that hippurate may be a useful diagnostic of Crohn's disease given that it is found at 421 significantly lower levels in the urine of patients (110) and that the gut microbiome's production of 422 benzoate is responsible for these differences in urinary hippurate (111) . Our results are inconsistent 423 with this prior work in such that they indicate that intestinal benzoate biosynthesis is higher in sick 424 animals. This difference may be due to variation in the host species being investigated, including how 425 benzoate is subsequently metabolized in the gut or by the host. Alternatively, the potential of the DNR 426 microbiome to make excess hippurate may not be realized given that we performed DNA sequencing.
427
Future mechanistic studies could measure benzoate and hippurate and quantify the benzoate proteins 428 at the RNA or protein level in DNR versus WT mice.
Most of the taxonomic and functional IBD biomarkers we identified are increasingly abundant in DNR mice throughout the disease process. But three modules show the opposite trajectory and decrease in system, acting in a stimulatory manner in early infection, and in an immunomodulatory manner in cases 
448
Lipooligosaccharide transport is the only module to show significant differences in abundance 449 trajectories both pre-and post-activation. Intriguingly, it is consistently lower in DNR versus WT mice 450 throughout our study with the largest difference during weeks 4-7, prior to immune activation and 451 disease symptoms. This finding initially seems surprising, because lipooligosaccharides are the major 452 glycolipids that are produced by mucosal Gram-negative bacteria and are known to have 453 proinflammatory effects (116). However, the two genes (NodI and NodJ) in the lipooligosaccharide changes in IBD is an exciting future direction. Regardless of mechanism, the consistent and pre-458 symptomatic depletion of lipooligosaccharide transport genes in DNR mice make this module a 459 promising candidate biomarker for predicting and diagnosing IBD.
461
We relied on a mouse model to quantify the longitudinal interaction between the gut microbiome and 462 disease because the extensive inter-individual variation in human genetics, lifestyle, microbiome 463 composition, and disease status and severity can complicate study design, analysis, and interpretation.
464
We used the DNR mouse model because it is relevant to our understanding of the mucosal 465 immunological dysregulation that occurs during human IBD and, consequently, its interaction with the 466 gut microbiome. Indeed, we observe immune activation in the blood of the DNR mice that is consistent 467 with what has been observed in human IBD (119). The phenotype observed in DNR mice is akin to 468 severe Crohn's disease with relatively substantial immunological activation and weight loss by week 12.
469
Interpretations of the microbiome-disease interaction in this model should be considerate of this 470 relatively severe disease status. Alternative mouse lines may be better models for other forms of IBD.
471
Another consideration is that we found some baseline differences in microbiome protein abundances in study. Four co-housed WT-RAG1+/+ and five co-housed DNR-RAG1+/+ littermates were followed 502 longitudinally for 15 weeks and fresh fecal samples were collected weekly and stored at -30° C until 503 they were subject to microbiome processing. All mice from both cohorts were weighed weekly.
504
All animal experiments were conducted in accordance with guidelines set by the Institutional Animal
505
Care and Use Committee of the University of California, San Francisco.
507
Immune sampling 508
Tail vein blood samples were collected weekly from a parallel cohort of "bleeder" mice to quantify how 509 their immune status changes over time (n=6 WT, n=6 DNR). These are distinct individuals from the repeated tail vein blood sampling from affecting the health or microbiota of the cohort of pooper mice.
512
Specifically, ~100 μl (2-3 drops) of blood from tail vein was added to 30 μl of 1x heparin (500 units/ml). 513 500 μl of 1x ACK lysis buffer (Lonza) was added directly to the cells and incubated at room temperature 514 for 2-3 min. Cells were centrifuged at 4000 rpm for 5 min. The top layer was aspirated and another 500 515 ml of 1x ACK lysis buffer was added followed by centrifugation. Cells were resuspended in FACS buffer 516 (PBS + 0.5% FBS) and after blocking Fc receptors with anti-CD16/CD32, single-cell suspensions were 517 incubated with FITC CD4 (GK1.5), PE CD62L (MEL14), PerCP-Cy5.5 CD8a (53.6.72), and APC CD44 518 (IM7) mouse antibodies for 30 min at 4°C. Stained cells were washed and acquired on an Accuri C6 519 cytometer (BD). Blood lymphocytes were gated on CD4+ or CD8+ fractions and percentage of 520 activated/memory (CD44hi) among CD4+ and CD8+ T cells was determined using FlowJo software 521 (Tree Star Inc.). This cohort was separated from those subjected to microbiome sampling to eliminate 522 the effect that repeated bloodletting might have on the microbiome. At 15 weeks of age, two WT and 523 three DNR from the non-bleeding animals were euthanized. Spleen and mesenteric lymph nodes were 524 then processed into single-cell suspension and subjected to ACK lysis and cell surface staining as 525 described for PBMCs. The status of T cell activation was quantified and found to highly correlate with 526 the blood immune status of their "bleeder" littermates (Additional Data File 2: Figure S2 and Additional 527 Data File 3: Table S1 ). instructions to process stool samples collected at weeks 5 and 13. Kit type was adjusted for in 534 statistical modeling to account for any potential differences in extraction bias between the two methods.
535
Purified DNA was prepared for shotgun metagenomic sequencing using the Nextera XT library 536 preparation method (ILLUMINA, San Diego, CA USA). Libraries were quality assessed using qPCR and Illumina HiSeq 2000. This produced an average of 74,427,303 100-bp paired-end sequences per sample. Metagenomic reads were quality controlled using the standard operating procedure defined by (GRCm38) using bmtagger (124). Exact duplicate reads were collapsed and the subsequent high-543 quality data was subject to taxonomic and functional annotation. Functional annotation of 544 metagenomes was conducted using ShotMAP as described in (16) 
562
The compound Poisson generalized linear mixed effects model implemented in the cplm 563 package in R (132) was used to find KEGG modules with a significantly different time trend between 564 groups while controlling for static differences between the lines and DNA extraction procedure (QIAGEN versus MOBIO). Random intercepts and slopes for both subjects and contributing KOs were 566 used to capture variation between subjects and between genes while focusing on the large scale shifts 567 over the whole collection of abundance profiles contributing to a module. As described more thoroughly 568 in Supplementary Text S1, the general computational procedure consisted of subsetting the data to 569 each module's relevant KO abundances and fitting a full model that described the RPKG abundance as 570 a function of time, group, time by group interaction, sequencing kit and random effects of each KO and 571 individual. We then use two reduced models, dropping first the interaction term and then the group 572 term, to obtain p-values via likelihood ratio tests. This is one of the recommended significance testing 573 approaches for mixed models since it avoids using approximations for the residual degrees of freedom 574 that would be necessary to test significance via the t-statistic (66). To limit the number of modules 
586
To differentiate functional changes occurring prior to immune activation, we fit a second hinge 587 regression to the abundances of modules that were found to have a significant time by group 588 interaction in the main GLMM analysis. This second regression placed a break point at week 7, which 589 represents the point at which immune activation initiated (Fig. 1) . This allowed for two sets of slopes 590 (before disease onset and after) and two sets of time by group interactions (representing deviations of Alterations in the species trajectory curves were additionally tested with an alternate method Week NMDS Dimension 1 
